Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
Portage Biotech Inc. (PRTG)
Company Research
Source: GlobeNewswire
WESTPORT, Conn., March 26, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today reported that it has completed selling its equity holding in Intensity Therapeutics (NASDAQ: INTS). Portage was an early INTS investor and during the past few months, Portage has been able to monetize its equity holdings in INTS and bring in proceeds, net of related expenses, totaling $2.8M of non-dilutive funding. The Company will use the proceeds to further fund its PORT-6 Phase 1a portion of the ADPORT-601 trial. “The Company looks forward to submitting interim data from the Phase 1a portion of ADPORT-601 (PORT-6) to the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in June and final data on the primary endpoints and any available data on secondary endpoints to the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting in November,” sai
Show less
Read more
Impact Snapshot
Event Time:
PRTG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRTG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRTG alerts
High impacting Portage Biotech Inc. news events
Weekly update
A roundup of the hottest topics
PRTG
News
- Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives [Yahoo! Finance]Yahoo! Finance
- Portage Biotech Announces Plans to Expand its Evaluation of Strategic AlternativesGlobeNewswire
- Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares [Yahoo! Finance]Yahoo! Finance
- Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update [Yahoo! Finance]Yahoo! Finance
- Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business UpdateGlobeNewswire
PRTG
Earnings
- 8/30/23 - Miss
PRTG
Sec Filings
- 4/12/24 - Form 424B3
- 4/12/24 - Form 6-K
- 3/8/24 - Form 424B3
- PRTG's page on the SEC website